Google-backed 23andMe hits major milestone: 100,000 users in DNA database
By Peter Delevett,
Mercury News
| 06. 15. 2011
Mountain View genomics startup 23andMe just hit a milestone: As of Wednesday, 100,000 people have uploaded their genetic code to the 4-year-old company's database.
Co-founder and CEO Anne Wojcicki says her scientists now have one of the world's largest genetic databases, which will enable them to do "a tremendous amount of discovery" into the possible causes of ailments such as Parkinson's disease. The company is also helping customers better understand their own DNA, the genetic blueprint that determines everything from whether someone is prone to breast cancer to whether their urine smells funny after eating asparagus (for 70 percent of us, the answer's yes on the latter).
But critics worry that 23andMe and other such genomics companies are misleading consumers with DNA profiles that don't tell nearly as much about their health -- good or bad -- as many might think. And in 23andMe's case, they've raised questions about the fact that one of the company's chief financial backers is Google (GOOG) -- whose co-founder, Sergey Brin, is Wojcicki's husband.
In a rare interview, Wojcicki spoke frankly about those controversies...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...